Earnings up almost 15%! Is it time to seriously consider this FTSE 250 stock?

Ongoing recovery and growth in this high-performing FTSE 250 business means there may be more to come for investors.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Person holding magnifying glass over important document, reading the small print

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With adjusted profit before tax up 52%, it’s clear FTSE 250 company CMC Markets (LSE: CMCX) has been trading well.

Today’s (20 June) full-year results report shows earnings per share shot up by almost 15% in the 12 months to 31 March 2024. The directors pushed up the shareholder dividend for the year by 12% in celebration.

The share price is responding well. But I reckon there may be more to come for shareholders as recovery and growth in the business plays out in the months and years ahead.

The enterprise is “one of the world’s leading” online financial trading businesses. To me, that means its operations tend to cycle with volatility in the markets.

In other words, when shares, commodities, cryptocurrencies and other instruments are pinging about all over the place, CMC Markets will likely make its best profits. That’s because investors and traders tend to participate more during volatile times.

Cyclical risk

It makes sense, then, that the firm has enjoyed a good year. The stock market took off last autumn and hasn’t looked back. All those stocks and commodities shooting higher just add up to another kind of volatility. Indeed, shares can go up as well as down, and that’s something that’s easy to forget!

The company reckons it serves retail and institutional clients via regulated offices and branches in 12 countries with a “significant presence” in the UK, Germany, Singapore and Australia.

It offers some 12,000 financial instruments that clients can trade via contracts for differences (CFDs). Financial spread betting is also on offer in the UK and Ireland. On top of that, the company provides stockbroking services in the UK, Singapore and Australia.

That looks like decent diversification of operations, but there are risks here. Perhaps the main one is the cyclicality in operations. The multi-year financial and trading record shows the business had previously endured a tough time.

Normalised earnings plunged in 2019, 2022 and 2023. So investing in the stock is not a one-way guaranteed ticket to the moon. In fact, the share price plunged by more than 80% between the spring of 2021 and the autumn of 2023.

Nevertheless, the company now has a cost efficiency programme in place to “drive profit margin expansion”.

Building growth

Chief executive Lord Cruddas said a recovery in client trading drove the good results for the year. On top of that, a diversification strategy using business-to-business (B2B) technology and an “institutional first” approach delivered strong growth and enabled “many” opportunities around the world. 

Cruddas reckons the strategy is based on continuous product launches and multiple application connectivity. The firm is making progress expanding its B2B and institutional business, with “limited competition”.

The outlook is positive, and City analysts predict an almost 20% increase in earnings for the current trading year with the dividend rising by more than 20%.

Meanwhile, with the share price near 299p, the forward-looking price-to-earnings ratio is just above 17 when set against that estimate. The anticipated dividend yield is just below 2.9%.

That’s not a bargain-basement valuation. Nevertheless, there’s a healthy net cash position shown on the balance sheet. So I’d research further now with a view to picking up a few of the shares aimed at capturing potential further recovery and growth in the business.

Kevin Godbold has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Caucasian woman with pink her studying from her laptop screen
Investing Articles

New to investing? Here’s Warren Buffett’s strategy for starting from scratch

Warren Buffett says he could find opportunities to earn a 50% annual return in the stock market if he was…

Read more »

Investing Articles

Can the sensational Barclays share price do it all over again in 2026?

Harvey Jones is blown away by what the Barclays share price has been doing lately. Now he looks at whether…

Read more »

Investing Articles

Prediction: in 2026 mega-cheap Diageo shares could turn £10,000 into…

Diageo shares have been burning wealth lately but Harvey Jones says long-suffering investors in the FTSE 100 stock may get…

Read more »

Investing Articles

This overlooked FTSE 100 share massively outperformed Tesla over 5 years!

Tesla has been a great long-term investment, but this lesser-known FTSE 100 company would have been an even better one.

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

I’m backing these 3 value stocks to the hilt – will they rocket in 2026?

Harvey Jones has bought these three FTSE 100 value stocks on three occasions lately, averaging down every time they fall.…

Read more »

Investing Articles

Can the barnstorming Tesco share price do it all over again in 2026?

Harvey Jones is blown away by just how well the Tesco share price has done lately, and asks whether the…

Read more »

Investing Articles

Up 45% in a year with a 7.2% yield and a P/E of 13! Is it too late to buy this fabulous FTSE 250 stock?

Harvey Jones spotted the potential in this ultra-high-yielding FTSE 250 recovery stock, and is thrilled to see it starting to…

Read more »

Investing Articles

What on earth’s going to happen to the BP share price in 2026?

Harvey Jones looks at how the BP share price is shaping up for the year ahead, and finds investors have…

Read more »